J. Mark Sutton
10Patents
4h-index
11Co-inventors
53Inventor score
Filing activity: Sep 12, 2002 → Jul 8, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7192596B2 | Recombinant toxin fragments | Emerging Cross-Sectional Technologies | 81 | Expired |
| US8389208B2 | Biological indicator | Chemistry; Metallurgy | 7 | Active |
| US7674470B2 | Recombinant toxin fragments | Emerging Cross-Sectional Technologies | 6 | Active |
| US7897158B2 | Recombinant toxin fragments | Emerging Cross-Sectional Technologies | 5 | Active |
| US9102976B2 | Biological indicator | Chemistry; Metallurgy | 4 | Active |
| US8012491B2 | Recombinant toxin fragments | Emerging Cross-Sectional Technologies | 3 | Active |
| US9416396B2 | Covalently linked thermostable kinase for decontamination process validation | Emerging Cross-Sectional Technologies | 3 | Active |
| US8012479B2 | Recombinant toxin fragments | Emerging Cross-Sectional Technologies | 2 | Active |
| US10466245B2 | Covalently linked thermostable kinase for decontamination process validation | Physics | 2 | Active |
| US9006395B2 | Recombinant toxin fragments | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.